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1. Summary  
Research shows that vaccine hesitancy (i.e. ‘the delay in acceptance or refusal of vaccines 
despite the availability of vaccination services’ (WHO SAGE, 2014a) is rising, resulting in 
alarming figures on disease outbreaks reported globally. Despite availability of vaccines, the 
number of countries reporting hesitancy has steadily increased since 2014 (Lane et al., 2018). 
Therefore, there is a need to understand what governments and partners can do to tackle this 
problem.  
The evidence for this rapid review is gender blind and taken from grey literature, including 
systematic reviews, interviews, research reports, and peer-reviewed academic papers from 
vaccine-related projects (e.g. Vaccine Confidence Project). Strategies aimed at specific 
populations in grey literature differed from those in peer reviewed literature (WHO SAGE, 
2014a). This review does not focus on anti-vaccination (anti-vaxx/anti-vac) sentiments or 
movements. Drivers of vaccine hesitancy are also not explored in this review.  
Key points include: 
 Definition: The “3Cs” (complacency, convenience, and confidence) World Health 
Organization (WHO) definition of vaccine hesitancy proposed in 2011 is used widely by 
governments as a standard term (MacDonald & SAGE, 2015). The more positive term 
‘vaccine confidence’ is also used by the Vaccine Confidence Project and US National 
Vaccine Advisory Committee. 
 Guidance for policymakers: Evidence shows that integrated stakeholder approaches, 
such as National Immunization Technical Advisory Groups (NITAGs), can provide 
guidance for policy developments and strengthen national vaccine decision-making, by 
acting as referees or technical resources in response to rumours or hesitancy (Howard et 
al., 2018).  
 Guidance for healthcare workers (HCWs): HCWs can also be hesitant, whether 
considering vaccination for themselves, their children, or their patients (ECDC, 2015). 
Guidance tools for healthcare professionals from around the world are available to 
empower them to become more effective advocates of vaccination (e.g. European Centre 
for Disease Prevention and Control); some of which have been adapted for use in other 
countries using WHO guidance (e.g. Guide to Tailoring Immunization Programmes or 
Western Pacific Regional Guidance).  
 Guidance to address parents: Researchers have also developed recommendations for 
health professionals and regulatory agencies to address parents’ hesitancy about 
vaccinations (ADVANCE Toolkit; US PolicyLab and the Vaccine Education Center). 
 Potential methods to tackle vaccine hesitancy: These include adopting a lower-profile 
approach (i.e. reducing frequency of vaccination campaigns) in order to avoid renewed 
suspicions (Pakistan). Adapted storytelling strategies can be used by individuals to tell 
personal stories about vaccines (Jacobs, 2018). Immunisation Information Systems (IIS) 
could help to fight vaccine hesitancy through recording additional information regarding 
reasons for delay, interruption or refusal of vaccinations (Gianfredi et al., 2019). 
However, a review by Schuster et al. (2015) revealed gaps in knowledge due to the 
paucity of studies in low- and middle-income country (LMIC) settings. 
 Effective strategies to decrease hesitancy: These include use of mass media; (tailored) 
communication tool-based training for HCWs (Centers for Disease Control and 
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Prevention); non-financial incentives, and reminder/recall-based interventions (Jarrett et 
al., 2015). Approaches can be applied in combination or individually, depending on the 
grade of vaccine hesitancy and funding available (Arede et al., 2019). Use of religious 
leaders/community influencers in community engagement strategies to address negative 
perceptions has also been successful (e.g. Nigerian Community Engagement 
Framework). The Stop HPV – stop cervical cancer information campaign has been 
successful due to collaborations between health agencies and social media (Denmark). 
 Lessons learned: A unidirectional (top down) approach to communication is successful 
among some individuals and groups, but not all; success is dependent on the nature and 
degree of hesitancy (Jarrett et al., 2015). Familiarity and trust with the messenger is a 
key feature in tackling hesitancy (WHO SAGE, 2014a; Nayar et al., 2019). Vaccine 
hesitancy and political populism are driven by similar dynamics: a profound distrust in 
elites and experts (Kennedy, 2019). Many experts believe that it is best to counter 
hesitancy at the population level (Kumar et al., 2016). Lessons learned have been 
compiled in the Catalogue of interventions addressing vaccine hesitancy technical report 
(ECDC, 2017). Some countries have turned to mandatory vaccination programmes 
(USA, France – albeit temporarily) – however experimental evidence shows that making 
one vaccine mandatory might reduce people’s uptake of others (Omer et al., 2019). 
Other approaches include penalties for non-compliance (Germany, Italy), or making 
vaccination a requirement for enrolment in childcare and school, which can help to 
increase rates (USA, Australia). Although popular, the effectiveness of promoting 
alternative vaccination schedules to decrease hesitancy has not been studied 
conclusively enough (National Research Council, 2013; Feemster, 2016).  
2. Definitions of vaccine hesitancy 
From 2000 to 2017, measles vaccination prevented an estimated 21.1 million deaths (WHO, 
2019a). However, at the same time, routine immunisation uptake of the first dose of a measles-
containing vaccine (typically measles-mumps-rubella, MMR), has declined in 12 EU member 
states (Larson et al., 2018). This has contributed to a rise in the number of measles outbreaks 
across the European region; resulting in over 82,000 cases and the deaths of 72 children and 
adults in 2018 (WHO Europe, 2019a). This escalation can be seen across the world, with 
measles outbreaks also in the US, Philippines, Myanmar, and Brazil (Whitford, 2019). Across the 
world, scepticism about vaccines is on the rise, leading to lower uptakes of key vaccines, and 
subsequently to the spread of diseases (APPG, 2019: 3). According to a recent Gallup survey 
(Wellcome, 2019), the most striking example is France, where an upsurge in measles cases has 
accompanied collapsing faith in all vaccinations: one in three French people (33%) regard 
vaccines as unsafe - the highest level in the world. 
‘Vaccine hesitancy’ has become the focus of growing attention and concern globally, despite 
overwhelming evidence of the value of vaccines (Marti et al., 2017). It is increasingly becoming a 
factor in low and stalling immunisation rates (APPG, 2019: 24). Since 2014, the number of 
countries reporting vaccine hesitancy has steadily increased (Lane et al., 2018). WHO/UNICEF 
Joint Reporting Form data from 2015–2017 states that only 14 countries out of 194 reported no 
vaccine hesitancy (Lane et al., 2018; APPG, 2019: 24), although an even lower value (seven 
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countries) was reported in 2017 (WHO, 2018: 1, 8). This led the WHO to announce vaccine 
hesitancy as one of the top ten threats to global health in 2019.1 
‘Vaccine hesitancy’: WHO SAGE 
Vaccine hesitancy is known as a ‘delay in acceptance or refusal of vaccines despite the 
availability of vaccination services’ (WHO SAGE, 2014a: 7).  
As their review of the literature did not reveal an established definition, the WHO Strategic 
Advisory Group of Experts (on Immunisation) Vaccine Hesitancy Working Group in 2013-2014 
defined hesitancy and its determinants (WHO SAGE, 2014a: 7; MacDonald & SAGE, 2015).2 
The Working Group retained the term ‘vaccine’ rather than ‘vaccination’ hesitancy. Although 
vaccination hesitancy more correctly implies the broader range of immunisation concerns, as 
vaccine hesitancy is the more commonly used term, The Working Group accepted the term 
‘hesitancy’ and then explored potential factors needed in its definition (MacDonald and SAGE, 
2015). The definition was made in order to ensure that immunisation programme managers, 
policy makers, clinicians, and researchers would consistently use a standard term to cover the 
broad range of factors causing low vaccine uptake, which excludes those not related to 
personal/community behaviour choices (MacDonald and SAGE, 2015). The Working Group 
noted that vaccine confidence was too narrow a term, covering only one category of factors that 
affect vaccine acceptance decisions (WHO SAGE, 2014a: 9). 
‘Confidence in Vaccines’: National Vaccines Advisory Committee  
‘Hesitancy’ and ‘confidence’ have been used in the literature to describe those individuals who 
fall in the middle of “a continuum ranging from complete refusal to complete acceptance of all 
recommended vaccines administered at the recommended times” (NVAC, 2015: 577; Peretti-
Watel et al., 2015). Reluctance, hesitation, concerns, or a lack of confidence have caused some 
parents to question or forego recommended vaccines (NVAC, 2015: 575). As significant gaps 
exist in measuring, monitoring, and tracking vaccine confidence, the US National Vaccines 
Advisory Committee (NVAC) put together a Vaccine Confidence Working Group (VCWG) in 
February 2013 (NVAC, 2015: 574). For the VCWG, ‘vaccine confidence’ refers to the trust that 
parents or health-care providers have (1) in the immunisations recommended by the Advisory 
Committee on Immunization Practices (ACIP); (2) in the provider(s) who administer(s) vaccines, 
and (3) in the processes that lead to vaccine licensure and the recommended vaccination 
schedule. When confidence is high, people will likely support immunisation recommendations 
and follow recommended schedules. When confidence is low or lacking, people are more likely 
to hesitate, and may decide to delay or forego recommended vaccinations (NVAC, 2015: 576). 
                                                   
1 https://www.who.int/emergencies/ten-threats-to-global-health-in-2019  
2 Vaccine hesitancy is complex and context specific, varying across time, place, and vaccines. It includes factors 
such as complacency, convenience, and confidence. This definition – known as the “3Cs” model of hesitancy in 
2011 - encapsulates the possible drivers of vaccine acceptance or refusal (see Larson et al., 2018: 6). However, 
measuring five psychological antecedents of vaccination (5Cs: confidence, complacency, convenience, risk 
calculation, and collective responsibility) that synthesise prior models of vaccine hesitancy and confidence has 
recently been proposed [see Betsch et al., 2019: https://doi.org/10.31234/osf.io/we2zb]. Whilst vaccine hesitancy 
in industrialised countries is influenced by the “5Cs model”, the knowledge gap surrounding the reasons for 
vaccine hesitancy in low- and middle-income country (LMIC) settings requires a more multi-sectorial research 
focus (see Cooper et al., 2018: 10.1080/21645515.2018.1460987 and Madhi & Rees, 2018: 
https://doi.org/10.1080/21645515.2018.1522921 for more information). 
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3. Guidance/Recommendations for development of vaccine 
policies 
The growing concern about vaccine hesitancy is reflected in the creation of guidance for 
stakeholders (e.g. governments, public health institutions, healthcare professionals etc.), as well 
as for parents/caregivers. The following is a list of examples used around the world:  
Stakeholders 
i. National/Regional Immunization Technical Advisory Groups 
National and/or Regional Immunization Technical Advisory Groups (NITAGs/RITAGs) are 
examples of an integrated approach to prevent vaccine hesitancy (see Section 5.iii). These 
technical resources can supply guidance to national policy makers and programme managers, to 
enable them to make evidence-based immunisation related policy and programme decisions 
suited to the locality (Duclos, 2010; Howard, 2018; WHO, 2018: 8). Multi-country comparative 
research shows that they have strengthened national vaccine decision-making, engaging with 
healthcare professionals, and acted as referee/technical resources in response to vaccine 
rumours or hesitancy (Howard et al., 2018). NITAGs can contribute to the National immunisation 
programme, including tailoring of recommendations, being country-advocates, and assisting in 
monitoring and advising on immunisation matters. Guidance by the Regional Immunization 
Technical Group will contribute to the 2018 Global Vaccine Action Plan (GVAP) goals of country 
ownership and universal vaccine coverage that is free of inequity (WHO, 2018).  
Evaluation: The number of countries with functioning NITAGs increased by 20% in 2017 (WHO, 
2018: 8). Many LMICs have established NITAGs over the past decade (Howard, 2018). For 
example, the Pakistan NITAG was established in 2008 by the Ministry of Health, in accordance 
with WHO guidelines. A programme policy/guideline document was developed in 2015 with the 
support of partners.3 This document lays out policy direction and guidelines for involvement of 
female health workers in immunisation service delivery, as well as the private sector’s role in 
immunisation. However, in 2016 only 43% of 47 African countries had an established NITAG, of 
which only two-thirds were assessed as functional (Adamu et al., 2018). Therefore, gaps remain 
in many African LMICs regarding immunisation performance, which needs to be addressed in 
order to understand hesitancy further (Wiyeh et al., 2018). 
ii. WHO European Region Guide to Tailoring Immunization Programmes (TIP) 
To better identify factors influencing vaccine hesitancy, WHO developed The Guide to Tailoring 
Immunization Programmes for infant and child vaccinations (WHO, 2013). It is targeted at 
National immunisation programme managers, together with WHO Europe technical officers. It 
includes proven methods and tools to diagnose vaccine-preventable disease in susceptible 
populations; identifies supply-and-demand barriers and enablers and recommends evidence-
based responses to build and sustain vaccination rates. The TIP principles are applicable to 
communicable, non-communicable, and emergency planning where behavioural decisions 
influence outcomes (Buttler et al., 2015). With application of these methods, governments can 
                                                   
3 Pakistan Expanded Programme on Immunization (EPI): http://www.emro.who.int/pak/programmes/expanded-
programme-on-immunization.html 
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shift away from traditional, expensive programmatic and/or regulatory interventions to lower cost, 
more subtle, effective, targeted interventions that have positive impacts in the selected problem 
subgroup (e.g. for immunisation, communicable or non-communicable disease control, outbreak 
control or emergency disaster planning). In times of fiscal constraint, this means that 
governments can deliver better services with better outcomes with fewer resources (Buttler et al., 
2015).  
Evaluation: An evaluation of the TIP tool was conducted in 2016. TIP has been applied 
successfully in a few countries (Bulgaria, Lithuania, Montenegro, Sweden, and the UK) to 
improve the understanding of concerns in vaccine-hesitant populations and develop targeted 
strategies. Other countries have initiated application of TIP, and the process is ongoing (ECDC, 
2017: 5).  
Public health professionals/institutions  
iii. WHO SAGE Recommendations 
WHO SAGE carried out a review (Schuster et al., 2015), and proposed a set of 
recommendations directed to the public health community, to WHO and its partners, and to the 
WHO member states (WHO SAGE, 2014b). The recommendations fall into three categories: (1) 
those focused on the need to increase the understanding of vaccine hesitancy, its determinants 
and the rapidly changing challenges it entails; (2) those focused on dealing with the structures 
and organisational capacity to decrease hesitancy and increase acceptance of vaccines at the 
global, national and local levels, and (3) those focused on the sharing of lessons learned and 
effective practices from various countries and settings, as well as the development, validation 
and implementation of new tools to address hesitancy (Eskola et al., 2015). 
iv. WHO Western Pacific Regional Guidance  
The WHO Western Pacific Regional Guidance on Addressing Vaccine Hesitancy to Help Foster 
Vaccine Demand guidance focuses on interventions that can increase vaccine uptake at the 
programme and individual levels. It has recently been adapted for use by healthcare 
professionals in Canada (MacDonald and Dubé, 2019). 
v. European Centre for Disease Prevention and Control Guides/Toolkits 
More and more studies show that healthcare workers themselves can be hesitant, whether 
considering vaccination for themselves, their children, or their patients. The ECDC provides 
guides and toolkits for healthcare workers, immunisation programme managers, and public 
health experts, to support their efforts in addressing vaccine hesitancy (ECDC, 2017). 
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vi. Learning Network for Countries in Transition/Vaccine Confident Project Resources 
The LNCT and the Vaccine Confidence Project have prepared a compilation of vaccine hesitancy 
and refusal resources for Gavi transitioning countries.4 The resources include global and country-
specific analyses, factors, and strategies to address it. 
Healthcare professionals and parents 
vii. US: PolicyLab Recommendations 
Paediatricians are considered as the most influential source for vaccine information (Siddiqui et 
al., 2013). The Vaccine Education Center at Children's Hospital of Philadelphia, US provides 
complete, up-to-date and reliable information about vaccines to parents and healthcare 
professionals. It is a member of the WHO Vaccine Safety Net. 
PolicyLab (within the CHOP Research Institute – one of the largest paediatric research institutes 
in the US) and the Vaccine Education Center recently released an Evidence to Action brief 
Addressing Vaccine Hesitancy to Protect Children and Communities against Preventable 
Diseases. The brief includes a review of vaccine hesitancy, identification of three areas of 
concern, and a series of recommendations to address the concerns (Nabet et al., 2017: 10, 17). 
viii. US Centers for Disease Control and Prevention Resources 
The CDC, under the US Department of Health and Human Services, is also working to address 
vaccine hesitancy. This includes creating new resources and updating existing CDC resources to 
counter misinformation. CDC continues outreach to the medical associations to help spread 
clear, consistent and credible vaccine information through trusted sources.5 It offers continuing 
education opportunities on vaccination, including training on how to improve vaccination rates. 
Available courses also include materials that health care educators can incorporate into existing 
medical school curricula (CDC, 2016).  
Evaluations of the individual-level interventions for parents to increase the likelihood that they will 
follow the recommended schedule for children are published in the Catalogue of interventions 
addressing vaccine hesitancy (ECDC, 2017: 19-23). Successes are found in behavioural 
interventions (addressing cervical cancer hesitancy in mothers), as well as tailored and corrective 
messaging (addressing MMR vaccination hesitancy). Messaging to parents must be tailored to 
meet individual needs as there is considerable variability in the specific issues of concern, as well 
as the types of messages which would be effective (Siddiqui et al., 2013). 
Parents/Guardians/Primary caretakers 
ix. US: National Vaccines Advisory Committee 
In 2015, the NVAC released Assessing the State of Vaccine Confidence in the United 
States (NVAC, 2015). This report identifies and describes: factors that may affect parental 
vaccine confidence; ways to improve parental vaccine confidence, and ways to measure vaccine 
                                                   
4 https://lnct.global/2018/11/14/vaccine-hesitancy-resources-for-gavi-transitioning-countries/ 
5 https://www.cdc.gov/media/releases/2019/t0429-national-update-measles.html 
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confidence to inform future interventions. The report also includes recommendations to the 
Assistant Secretary for Health (ASH) on how improving vaccine confidence can help reach 
Healthy People 2020 immunisation coverage targets. 
x. Parent Attitudes about Childhood Vaccines 
Research in first-time mothers found that they were three times more likely than others to identify 
as unsure, somewhat, or very vaccine hesitant (Corben and Leask, 2018). PACV is one of 
several tools developed to measure vaccine hesitancy (Opel, 2011; 2013). It is completed by 
parents to stratify them according to their level of vaccine hesitancy.  
Evaluation: PACV was validated in relation to acceptance of seasonal influenza vaccine in a 
paediatric emergency department setting in Washington State, US, but did not include all 
recommended childhood vaccines (Williams et al., 2015). Although a valid and reliable screening 
tool is necessary for identifying the target population of interest, the PACV and its overall score 
has not yet been shown to clearly distinguish parents who are potentially more amenable to 
change from parents who are not. For instance, two parents may both score highly on the PACV 
but may have very different reasons for hesitancy and different flexibility in their final vaccine 
decision making (Williams et al., 2015). It has been widely used in the Americas (Canada), Asia 
(India, Malaysia, The Philippines, Singapore), and Europe (England, Croatia) (Opel, n/d). The 
survey was found to be a successful surveillance tool to identify vaccine-hesitant parents (ECDC, 
2017: 7).6  
4. Approaches used to tackle vaccine hesitancy 
It is suggested that immunisation concerns are “co-opted to serve political purposes” (WHO, 
2017: 18). Vaccine hesitancy and political populism are driven by similar dynamics: a profound 
distrust in elites and experts (Kennedy, 2019). Working together to stimulate demand will also 
help to prevent hesitancy (WHO, 2018: 8). Hesitancy can be caused by individual, group, and 
contextual influences, as well as any vaccine-specific issues (WHO, 2019c). Hesitancy in relation 
to vaccination may affect motivation, causing people to reject it for themselves or their children. 
The following approaches to tackle hesitancy can be applied in combination or individually, 
depending on the grade of vaccine hesitancy and funding available (Arede et al., 2019): 
Laws mandating vaccines and fines 
There is a need to understand the variety of ways in which legislation and regulation have been 
used to advance the cause of immunisation (including its use to address hesitancy), the impact 
of such measures, and the contextual factors that have influenced their effectiveness (WHO, 
2017: 19). The following country evidence are examples of government laws mandating 
vaccines:  
                                                   
6 In comparison, using data from a large population-based survey conducted among parents of children aged 24–
35 months, Smith and collaborators (2011) concluded that the four psychosocial domains of the health belief 
model (perceived susceptibility to, and seriousness of, vaccine-preventable diseases; perceived efficacy of 
vaccines, and concerns and influences that facilitate or discourage vaccination) allowed for measurement of 
beliefs linked with vaccine hesitancy and could be useful for predicting the parental decision to delay or refuse 
vaccines for their child (see Smith et al., 2011: DOI:10.1177/00333549111260S215). 
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US: Laws mandating vaccines for school entrance are state-based. Hence, there is 
substantial variability in the laws across the country. These are based on coverage of 
school grades, vaccines included, introduction of new vaccines, reasons for exemptions, 
and procedure for granting these exemptions. Mandatory immunisation laws for school 
entrance were designed to control outbreaks of vaccine preventable diseases such as 
smallpox and measles (Orenstein & Hinman, 1999). However, certain exemptions are 
permitted to school entrance immunisation laws in each state. All states, besides 
Mississippi and West Virginia, permit religious exemptions, while only 20 states permit 
philosophical or personal belief exemptions (Siddiqui et al., 2013). 
In light of rising vaccination hesitancy, some European countries have turned to mandatory 
vaccination programmes, including rigid penalties for non-compliance. However, experimental 
evidence shows that making one vaccine mandatory might reduce people’s uptake of others 
(Omer et al., 2019): 
France: New laws that took effect from the beginning of 2018 now make it mandatory for 
parents to vaccinate their children against diseases.7 The move followed a rash of 
measles deaths across Europe. To help reduce this scepticism and combat rejection 
rates, the French government expanded the number of compulsory vaccines from 3 to 11 
for children up to the age of 2 years. In addition to the new law, the government is 
conducting promotional campaigns and providing additional support to healthcare 
professionals who have vaccine-hesitant patients. The mandate is intended to be 
temporary until the government sees evidence of higher confidence among the public 
(Rey et al., 2018). 
Italy: In February 2017, the Ministry of Health issued the 2017–2019 National 
Immunisation Prevention Plan, and in July 2017 the law 119/2017 for compulsory 
vaccination was approved.8 As of September 2017, new law 73/2017 calls for children to 
receive 12 vaccines if they want to be enrolled in school (Crenna et al., 2018).  
Germany: Although no legal mandate exists, parents now face a hefty fine of 2,500 euros 
(£2,175; USD 2,800) if they don’t immunise their children.9 Since 2015, parents in 
Germany must present proof that they have received medical vaccination advice to 
childcare centres. However, the centre is not allowed to refuse a child a place if they 
have not done so, as parents have a legal right to one. Unlike Italy, Germany has not 
made it mandatory for children to receive certain vaccinations before being accepted by 
childcare centres, although many doctors and parties such as the Free Democratic Party 
(FDP) have called for such a law. 
Finland: general vaccination acceptance is “very good”10 and coverage is “excellent.”11 
However, according to the Ministry of Health’s chief physician, parliamentarians have 
                                                   
7 https://www.efe.com/efe/english/technology/france-makes-11-child-vaccines-compulsory-no-school/50000267-
3480979 
8 Italia. Ministero della Salute. National Immnunization Prevention Plan 2017-2019. Published on the Italian 
Official Gazette, 18 February 2017. www.gazzettaufficiale.it/eli/id/2017/02/18/17A01195/sg 
9 https://www.dw.com/en/germany-moves-to-improve-child-vaccination-rate/a-39004792 
10 
https://yle.fi/uutiset/osasto/news/frustrated_and_disappointed_one_father_asks_why_finland_wont_make_childh
ood_vaccines_compulsory/10023122  
11 https://thl.fi/en/web/vaccination/national-vaccination-programme/vaccination-programme-for-children-and-
adolescents  
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raised concerns about lower vaccination coverage rates in some parts of the country and 
have pondered ways to address the problem.10 
Vaccine intervention strategies 
In their systematic review of interventions for reducing parental vaccine refusal and vaccine 
hesitancy, Sadaf et al. (2013) found limited evidence on effective strategies to guide policy 
makers. However, a number of such strategies have been reported by WHO SAGE and ECDC 
(Jarrett et al., 2015; ECDC, 2017):  
i. Dialogue-based interventions 
Leader involvement: Interventions with religious or traditional leaders align themselves with 
natural community processes – seeking out community leaders and encouraging dialogue across 
multiple levels to both inform and influence. Leaders include those from government, religious 
institutions, and the local community (both male and female). Research shows that success 
could be attributed to the efforts made to understand the target audience via open dialogue and 
integrate activities with familiar processes and systems (WHO SAGE, 2014a: 12; Jarrett et al., 
2015). For example, successful interventions relating to hesitancy on uptake of reproductive 
health technology (RHT) in African and South Asian centred on the interpretation of local 
religious and cultural norms, particularly around the understanding and perceptions of both men 
and women, to create an environment to support pro-RHT decision-making (WHO SAGE, 2014a: 
12). In 2018, a Community Engagement Framework (CEF) developed by the National Primary 
Healthcare Development Agency (NPHCDA), WHO and its partners, worked with traditional 
leaders in communities to quash social media rumours that the Nigerian Government had 
stopped free immunisations due to safety of the vaccines.12 NPHCDA and its partners also 
developed a Demand creation package, which uses community influencers such as Quranic 
teachers for mobilisation and health camps to provide free health services. 
Mass media: Mass media channels (e.g. television, radio, public transport advertising, and the 
internet) are among the best tools to communicate public policy to all segments of a community. 
This was found in India, where target parents with low awareness of health services in India 
found an association with increased uptake of all routinely recommended vaccines (Jarrett et al., 
2015). At a broader contextual level, group sessions with journalists and mass media campaigns 
have also been used to positive effect to support message consistency. 
Social media: There is a plethora of misinformation about vaccines, reducing public trust and 
confidence in their safety and efficacy. The rise of social media and “fake news” has only 
enhanced the spread of these messages (Whitford, 2019). Negative messages are circulated 
mostly via groups on social networking apps, such as WhatsApp, rather than by individual 
messaging. Most messages are anonymous and are forwarded without any content verification 
(Nayar et al., 2019). Arede et al. (2019) recommend that WHO, CDC, ECDC, and/or national 
health departments use social media platforms in order to inform the public, especially 
adolescents, about relevant scientific data (with financial support from international and national 
entities). For example, the Pakistani government is now considering different options on how to 
respond to the aftermath of the polio eradication panic (Yusufzai, 2019). These include adopting 
a lower-profile approach during the government-led immunisation campaign, in order to avoid 
                                                   
12 https://www.afro.who.int/news/nigeria-consolidates-efforts-curtail-vaccine-hesitancy 
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renewed suspicions started on social media (Liuhto, 2019). In addition, it is reported that the 
government and its partners have launched a perception management campaign to combat 
misinformation. This includes working with Google, Facebook, YouTube, and Twitter. 
Training for HCWs – communication tool-based: This generally has a positive effect (e.g. for 
Expanded Programme on Immunization (EPI) vaccines, DTP3); however, the size of the effect 
and evidence quality vary. Observations about this example and mass media suggest that 
interventions that adopt a unidirectional (top down) approach to communication may be 
successful among some individuals and groups, but not all; success is dependent on the nature 
and degree of hesitancy (Jarrett et al., 2015). However, the use of field workers instead of local 
opinion leaders was definitely not as effective as employing both in community group 
discussions. In certain contexts, defensive communication (e.g. debunking and fact checking) 
might reassure public health professionals and have some positive impact. Although, it does not 
address negative emotions towards vaccines, which causes hesitancy (Gesualdo et al., 2018). 
Training for HCWs – information-based tool: HCWs can also be hesitant, whether considering 
vaccination for themselves, their children, or their patients (ECDC, 2015: 1). Vaccine education 
tools, along with guidance from professional authorities like the ACIP and AAP (American 
Academy of Pediatrics), can help health providers overcome their own doubts regarding the 
safety and effectiveness of routine childhood immunisations. This is important as there is a need 
for communication of a unified message from healthcare providers to parents on the benefits of 
vaccines and their timely uptake in children (Siddiqui et al., 2013). Interventions focusing on 
improving knowledge of healthcare workers were mostly found to have a positive impact on 
vaccine uptake (ECDC, 2015: 8). However, unless the intervention is appropriately targeted, it 
will be unsuccessful (Jarrett et al., 2015). This is due to low confidence of HCWs.  
ii. Non-financial incentives 
By addressing basic needs such as food, this intervention simultaneously builds confidence and 
reduces vaccine hesitancy (Jarrett et al., 2015). This is because the target population feel that 
their other critical needs are being addressed. This approach could be particularly important for 
underserved groups (Jarrett et al., 2015). 
iii. Reminder-recall notifications 
In some countries, as vaccination services are private, the functions dedicated to recording of the 
vaccinated population are well separated from others dedicated to the management of 
vaccination process. Therefore, a system of written reminders can act as a follow-up mechanism 
with parents of unvaccinated or under-vaccinated children. One has been introduced in 
Denmark, with a “significant improvement” in vaccination levels (Sabin Vaccine Institute, 2018: 
9). 
However, although positive, the relatively low observed effect of reminder–recall interventions in 
LMIC settings seems to reflect the limitations of using this kind of intervention alone to tackle 
multiple causes of hesitancy (Jarrett et al., 2015).  
Measurement tools 
Different tools have been developed to measure vaccine hesitancy, identify hesitant populations 
(including clinicians and members of the public), and assess the concerns in hesitant populations 
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(Larson et al., 2015; ECDC, 2015). These include surveys with Likert scales, and open-ended 
questionnaires. However, evaluations are not always available (ECDC, 2017: 11). The following is 
a range of tools which have been used with positive results: 
iv. Vaccine Hesitancy Scale (VHS): Population surveys and monitoring 
New ways of analysing country responses are needed to provide a clearer picture of demand 
and hesitancy issues at a national level (WHO, 2018: 9). The availability of validated scales of 
vaccine hesitancy/confidence, and their regular use in a country, allows monitoring the 
antecedents of vaccination, and detecting potential early warning signals (Lane et al., 2018).  
Many experts are of the view that it is best to counter vaccine hesitancy at the population level. 
They believe that it can be done by introducing more transparency into policy decision-making 
before immunisation programmes, providing up-to-date information to the public and health 
providers about the rigorous procedures undertaken before introduction of new vaccines, and 
through diversified post-marketing surveillance of vaccine-related events (Kumar et al., 2016). 
First, Governments have to clarify if vaccine hesitancy is a leading cause of low vaccination rates 
in their country (Arede et al., 2019). Therefore, surveys on the vaccination status and attitude of 
the population should be performed using guidelines, such as the one provided by the WHO 
SAGE Working Group on vaccine hesitancy (WHO SAGE, 2018). WHO SAGE developed a 
diagnostic tool, the Vaccine Hesitancy Scale (VHS), to identify and compare hesitancy of parents 
in different global settings. It has been field tested in both rural and urban Guatemala (Domek et 
al., 2018), and in the UK for general attitudes (Luyten et al., 2019). However, problems 
interpreting the multiple constructs of vaccine hesitancy have been found (Domek et al., 2018).  
Each country will have to define their own evaluation framework to measure the success of their 
particular implementation. For example, Sweden conducted an analysis of the reasons behind 
lower immunisation rates among immigrant populations in several areas of the country and 
undertook a targeted information campaign. Similarly, Denmark conducted an analysis to 
discover the reasons behind the human papillomavirus (HPV) vaccine hesitancy and addressed 
it through a targeted information campaign (Sabin Vaccine Institute, 2018: 9). This tactic resulted 
in immunisation rates significantly improving. 
v. The ADVANCE consortium Toolbox 
The Accelerated development of vaccine benefit-risk collaboration in Europe has developed the 
ADVANCE Toolbox, which can be used by the scientific community and regulatory agencies to 
streamline the monitoring of the health benefits and risks of vaccines.13 It comprises of different 
online open source applications to assess potential impact of possible disease- and exposure-
misclassification; derive prevalence estimates and validity indices, and visualises near real-time 
monitoring.  
vi. The Vaccination Determinants Matrix  
The more complex Working Group Determinants of Vaccine Hesitancy Matrix has determinants 
arranged in three categories: contextual, individual and group, and vaccine/vaccination-specific 
                                                   
13 http://www.advance-vaccines.eu/  
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influences (WHO SAGE, 2014a: 12). While not primarily intended as a practical tool, this may be 
helpful for researchers, survey question developers, and those developing interventions to 
address hesitancy, to approach the problem more broadly than as simply an issue of confidence 
(MacDonald & SAGE, 2015). 
vii. Immunisation Information System: ongoing surveillance 
Immunisation Information Systems (IISs) are confidential, electronic population-based systems, 
storing individual-level data on vaccines received within a given geopolitical area. They are also 
known as immunisation registries, and in the majority of cases, data are entered by HCWs. 
Sometimes the general population may also enter data, followed by a general practitioner (GP)’s 
approval (Gianfredi et al., 2019). It is recommended that increased paediatrician or GP 
involvement would be helpful for determining vaccine hesitancy (Jacobson et al., 2015); 
especially as vaccine hesitancy can rapidly undermine coverage of specific vaccines, often in 
highly localised settings (WHO, 2017: 18).  
IISs have the potential to improve the performance of vaccination programmes and to increase 
vaccine uptake, as they are able to generate reminder and recall notifications. The strength of IIS 
is to provide decision makers with support for a vaccine strategy aimed to evaluate the efficacy of 
such vaccine policy, and to improve programme management (Siddiqui et al., 2013; Whitford, 
2019).  
Most IISs have additional capabilities, such as monitoring vaccine stocks to facilitate timely 
procurement of vaccines in order to limit wastage and ensure adequate supplies, as well as 
monitoring of adverse events following immunisation (AEFI) reporting, and communicating with 
other health information systems, in particular with civil and cancer registries (Gianfredi et al., 
2019).  
Another use specific to hesitancy is recording delay information. IISs could help to fight vaccine 
hesitancy through recording additional information regarding reasons for delay, interruption or 
refusal vaccinations. Alternative vaccination schedules offer delaying receipt of some vaccines or 
doses, selective avoidance of some vaccines, and limiting the number of vaccinations received 
by children at any visit to the physician’s office (Siddiqui et al., 2013). Delaying receipt of 
vaccines might increase susceptibility of children by exposing them to vaccine-preventable 
diseases. Alternative vaccine schedules have become popular; however, the safety or 
effectiveness of these schedules has not been rigorously studied (National Research Council, 
2013; Feemster, 2016). However, a review on vaccine hesitancy by Schuster et al. (2015) 
revealed gaps in knowledge especially due to the paucity of studies from LMICs settings. This is 
because several countries are still developing or piloting these instruments.14 
viii. Vaccine safety systems 
A rigorous vaccine safety system that takes advantage of new technologies and new scientific 
methods, along with effective communication approaches to address vaccine concerns, is key to 
maintaining public confidence (Siddiqui et al., 2013). The US has one of the most advanced 
systems in the world for tracking vaccine safety.15 These include the Vaccine Adverse Events 
                                                   
14 The ECDC provided the last updating data on IIS implementation among European countries, while WHO 
made available data for the other developing countries.  
15 https://www.vaccines.gov/basics/safety 
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Reporting System (VAERS)16 (an early warning system managed by CDC and FDA, for use by 
patients, health care professionals, vaccine companies, and others), and The Vaccine Safety 
Datalink (VSD)17 (a collaboration between CDC and several health care organisations across the 
nation). 
5. Effective responses to hesitancy ‘outbreaks’: lessons 
learned 
Countries vary greatly in their preparedness for hesitancy ‘outbreaks’ or declining coverage, with 
middle-income countries in particular typically lacking the capacity to manage hesitancy 
challenges (WHO, 2017: 19). The following lessons learned are necessary to consider for future 
responses to hesitancy ‘outbreaks’: 
i. Quality hesitancy assessments/trend information 
In 2016, 83% of countries reported at least one reason for hesitancy. However, only a third (33%) 
of countries had carried out a hesitancy assessment (WHO, 2017: 18). This number needs to be 
increased, as assessments are also key for determining if an intervention has been effective in 
reducing overall hesitancy (Lane et al., 2018). For this to happen, the barriers to undertaking 
assessments need to be determined. Increasing assessments would not only enhance the 
validity of the reasons cited, but when done serially e.g. before and after an intervention has 
been implemented, could help grow the evidence for what strategies work in what settings and in 
what contexts to improve vaccine acceptance. In the interim, when stakeholders are working with 
countries to address hesitancy and improve vaccine acceptance, if assessments are not 
available, it might be helpful to look at both regional trends, as well as trends by country income 
level to determine what concerns might most effectively be targeted to help the country (Lane et 
al., 2018). 
ii. Government investment in immunisation 
Data from the WHO shows that government investment in immunisation has grown by 108% in 
the African region and by 78% in the Western Pacific region since 2010, but has fallen by 12% in 
the European region (WHO, 2017: 18). Although the investment made by national governments 
in immunisation has been steadily increasing, a decline in the European region is worrying 
(WHO, 2017: 12). Newer NITAGs (e.g. Nigeria, Uganda, and Senegal) have expressed concerns 
about lacking guaranteed funding (Howard et al., 2018). UNICEF is currently urging governments 
in Europe and Central Asia to invest in health systems that prioritise reaching the most 
vulnerable children with life-saving immunisations, alongside national campaigns to address the 
concerning trend of growing vaccine hesitancy.18 
                                                   
16 https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/ 
17 https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vsd/ 
18 https://www.unicef.org/kyrgyzstan/press-releases/governments-must-invest-immunizing-most-vulnerable-
children-and-addressing-vaccine 
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iii. Integration with health programmes 
Integrating activities with familiar processes and systems has been shown to be successful 
(WHO SAGE, 2014a: 12; Jarrett et al., 2015; Adamu et al., 2018). An integrated approach 
includes involvement of stakeholders involved in evidence synthesis, programme managers, and 
those involved in vaccine delivery, as well as end-users (parents/caregivers). 
The lack of basic services in Pakistan and Afghanistan has fuelled vaccine hesitancy in some of 
the most deprived and underserved communities there.19 Therefore, the Global Polio Eradication 
Initiative (GPEI) 2019–2023 Strategy has initiated a new integrated model that responds to 
vaccine hesitancy and polio fatigue (WHO, 2019b: 41). UNICEF Country Offices in Pakistan and 
Afghanistan are working to integrate activities around health, WASH, nutrition, and education in 
these communities. 
iv. Target strategies 
An analysis of grey literature demonstrates that the strategies aimed at specific populations differ 
from the peer reviewed literature (WHO SAGE, 2014a: 34).20 Most strategies were aimed at the 
local community, HCWs, and parents, with some policy-based strategies aimed at government 
officials. All of these implemented a focus in Africa. However, strategies aimed at the local 
community were also common in high income regions, particularly in the Americas, as were 
strategies aimed at HCWs, parents and adolescents (WHO SAGE, 2014a: 34). 
Stakeholder collaborations: Each country should develop a vaccine hesitancy management 
strategy, to include ongoing national assessment of vaccine concerns, trust-building and active 
hesitancy prevention, and crisis response plans. This is the main responsibility of the countries 
themselves, as well as other key stakeholders, e.g. WHO regional offices, RITAGs, Global 
NITAG Network, associated technical experts, and civil society organisations (CSOs) (WHO, 
2017: 28). 
In Denmark, health authorities launched a media campaign to restore public confidence in 
response to negative media reports questioning the safety of the HPV vaccine, and a related 
decline in the number of teenage girls getting it. The results have been impressive: in 2017 
around 30,000 girls began the HPV vaccination programme, which is a doubling compared to the 
year before (WHO Europe, 2019b). Authorities conducted a survey and created several focus 
groups to better understand the concerns parents had with the HPV vaccination. They were 
eager to know who to target, and the results from the survey told them that it was primarily 
mothers who made the decisions. One of the most important facts gleaned from the survey and 
the focus groups was that parents wanted to learn more about the HPV vaccine. With that 
information the Danish Health Authority partnered up with the Danish Cancer Society and the 
Danish Medical Association to design the information campaign Stop HPV – stop cervical cancer. 
A public relations firm was hired to help communicate the message; a website was developed, 
and Facebook and other social media platforms were used to reach the target group (WHO 
Europe, 2019b). 
                                                   
19 http://polioeradication.org/wp-content/uploads/2019/01/polio-partners-group-chairs-statement-20181203.pdf  
20 The strategies were categorised into themes including: multi-component, dialogue-based, incentive-based and 
reminder/recall-based. Within the peer reviewed literature, most evaluated interventions were multi-component. 
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Children and adolescents: Vaccine hesitancy has several causes, and emotions play an 
important role. As a result of their literature review, Arede et al. (2019) suggest the alternative 
approach of stakeholders targeting children and adolescence, who might not have strong 
emotions about vaccines yet (and whose opinion can still be influenced through different 
sources). This is important, as in adults, the chances of improving risk perception solely by 
providing appropriate information are low due to the already established emotional connection to 
the topic of vaccination. Tools can differ according to different developmental periods. Investing 
into prevention and health promotion, as well as communicating the importance of vaccination to 
young generations can have long-lasting beneficial effects in the population (Arede et al., 2019). 
However, as it is likely to have a very heterogeneous group of hesitant people, it is crucial that 
the strategy is well adapted to a particular subgroup (Jacobs, 2018: 101). 
v. (Re-)building/understanding trust  
Allied to this work is the need to develop strategies for building and maintaining trust with 
communities – an area where several groups can play valuable roles (WHO, 2017: 19; WHO, 
2018: 12). The underlying dynamics of the relationship between governments and their citizens 
that help explain why finding appropriate, and effective, policy responses can be challenging. 
They are also not well documented (Kieslich, 2018): 
Government collaborations: Research has shown that, in the concept of trust, parents describe 
governments as ‘socially remote institution[s]’ rather than supportive when discussing vaccines 
(Dubé et al., 2016). Rebuilding trust about vaccines will require co-ordination between many 
different areas of government, including health, education, media and international development. 
Local communities, CSOs, and religious groups are also essential in building confidence in 
immunisation and must be given the tools to utilise their engagement in all areas of society 
(Whitford, 2019).  
Health professionals: As HCWs have the potential of influencing patient vaccination uptake, it is 
crucial to improve their confidence in vaccination, and engage them in activities targeting vaccine 
hesitancy among their patients (Karafillakis et al., 2016). However, state–society relations in 
vaccination policy are characterised by contestation over the credibility of scientific evidence and 
a distrust of citizens in public health institutions (Kieslich, 2018).  
It is recommended that clinicians should build trust with patients and their families, as well as 
build relationships with leaders in the community (Ashkir and Mohamed, 2017). Interventions that 
are less successful are those that did not engage closely with the individual. Specifically, the use 
of field workers instead of local opinion leaders was not as effective as employing both in 
community group discussions. Familiarity and trust with the messenger seem to be a key feature 
in these instances (WHO SAGE, 2014a: 12). Absence of trust between care givers and health 
workers is seen as an important issue in vaccine hesitancy (Nayar et al., 2019). Also, many 
parents no longer want to be told what to do for the health of their children by their paediatrician, 
but rather want a shared decision-making process (Siddiqui et al., 2013). 
CSOs: The field of state–society relations comprise not one approach, but multiple lenses that 
ascribe varying degrees of policymaking influence to state actors and society actors, respectively 
(Kieslich, 2018). Greater collaboration between immunisation actors, with civil society at the 
centre, is vital in order to counter attacks on immunisation and reach those children most in need 
(APPG, 2019: 3). On the national stage, CSOs can play a critical role in advocacy and in holding 
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governments to account. They also have the potential to make significant contributions to 
national hesitancy management strategies (WHO, 2017: 19).  
Communities: The EU-funded project EBODAC (Ebola Vaccine Deployment, Acceptance and 
Compliance) focuses on trust building and community engagement around recruiting participants 
into Ebola vaccine trials in Africa. It includes investigation of the evolution and impacts of 
negative rumours, such as those that led to the suspension of two Ebola vaccine trials in 
Ghana.21 The learnings from the EBODAC Consortium 2017 symposium have contributed to a 
training resource which is now available as an open-access tool for anybody who is interested in 
community engagement, communications and enabling technologies for clinical trials in outbreak 
settings.22 
Parents: A qualitative review from Canada shows that parental/caregiver vaccination decisions 
are complex and multi-dimensional (Dubé et al., 2018). There are genuine concerns that 
parents/caregivers have about vaccines and their possible side effects (Edwards et al., 2016). 
However, sometimes these concerns have been dismissed as uninformed or uneducated, but 
this is unhelpful and counterproductive (Whitford, 2019). Results taken from Freed et al. (2011) 
show that parents most often trusted their child’s paediatrician for safety information (76% 
expressed ‘a lot of’ vs ‘some’ trust), followed by other healthcare providers (26%), government 
vaccine experts (23%), and family and friends (15%). However, over a quarter (26%) of parents 
surveyed had placed some trust in celebrities (Freed et al., 2011). 73% of the parents placed at 
least some trust in other parents who believed that their child was harmed by a vaccine. 
Websites from doctor groups (e.g. the AAP) were the most popular source of information trusted 
by parents (used by 27%). Furthermore, there were gender differences among parents. Women 
were more likely than men to place at least some trust in parents claiming a vaccine hurt a child. 
Women were more likely to trust celebrities, television shows, magazines and news articles for 
vaccine safety (Freed et al., 2011).  
Therefore, those who design public health efforts to provide evidence-based information must 
recognise that different strategies may be required to reach some groups of parents who use 
other information sources. The government must bring in people with genuine fears for their 
children’s health, open the conversation, and rebuild trust around vaccines again. No question 
should be deemed unreasonable or unreasoned (Whitford, 2019). Public Health England is 
working with the Cabinet Office disinformation unit to include measles as one of topics being 
tested as part of the ‘Don’t feed the beast’ campaign. The campaign encourages people to use 
the S.H.A.R.E checklist to look for misleading news and content.23  
  
                                                   
21 https://www.vaccineconfidence.org/rise-vaccine-hesitancy-related-pursuit-purity/ 
22 Hosted by the Vaccine Confidence Project: https://www.vaccineconfidence.org/ebohandbook-introduction/  
23 https://sharechecklist.gov.uk/ 
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